Department of Internal Medicine, Rouen University Hospital, and INSERM U 905, University of Rouen IFRMP, Institute for Biochemical Research, Rouen, France.
Department of Digestive Physiology, Rouen University Hospital, and INSERM UMR 1073, University of Rouen IFRMP, Institute for Biochemical Research, Rouen, France.
Aliment Pharmacol Ther. 2016 Nov;44(10):1123-1133. doi: 10.1111/apt.13810. Epub 2016 Sep 28.
There are no studies on systemic sclerosis (SSc) assessing the relationship between food intake, especially lactose, and gastrointestinal dysfunction.
To determine the prevalence of lactose malabsorption, using lactose breath test, in patients with SSc. To evaluate the correlation between lactose malabsorption and gastrointestinal involvement. To predict which SSc patients exhibit lactose malabsorption.
Seventy-seven consecutive Caucasian patients with SSc and 20 control subjects underwent lactose breath test. All patients also completed a questionnaire on digestive symptoms, and a global symptom score (GSS) was calculated.
The prevalence of lactose malabsorption was higher in SSc patients than in controls (44.3% vs. 10%; P = 0.004). We observed a marked correlation between the presence of lactose malabsorption and: higher values of GSS (P < 0.0001); severe oesophageal (P = 0.018) and small intestinal (P = 0.04) motor disorders; and joint involvement (P = 0.019). Furthermore, in SSc patients with symptomatic lactose malabsorption, the median value of GSS of digestive symptoms was lower after initiation of lactose-free diet (P < 0.0001).
Our study underscores the fact that lactose malabsorption often occurs in patients with systemic sclerosis. Furthermore, our findings highlight the fact that lactose breath test is a helpful, noninvasive method, by identifying the group of patients with systemic sclerosis with symptomatic lactose malabsorption that may benefit from a reduction in lactose intake.
目前尚无研究评估系统性硬化症(SSc)患者的饮食摄入,尤其是乳糖摄入与胃肠道功能障碍之间的关系。
使用乳糖呼气试验确定 SSc 患者乳糖吸收不良的患病率。评估乳糖吸收不良与胃肠道受累之间的相关性。预测哪些 SSc 患者存在乳糖吸收不良。
77 例连续的高加索 SSc 患者和 20 例对照者接受乳糖呼气试验。所有患者还完成了关于消化症状的问卷,并计算了总体症状评分(GSS)。
SSc 患者中乳糖吸收不良的患病率高于对照组(44.3% vs. 10%;P=0.004)。我们观察到乳糖吸收不良的存在与以下因素之间存在显著相关性:GSS 值更高(P<0.0001);严重的食管(P=0.018)和小肠(P=0.04)运动障碍;关节受累(P=0.019)。此外,在有症状乳糖吸收不良的 SSc 患者中,开始无乳糖饮食后,消化症状的 GSS 中位数明显降低(P<0.0001)。
我们的研究强调了一个事实,即乳糖吸收不良在系统性硬化症患者中经常发生。此外,我们的发现强调了乳糖呼气试验是一种有用的、非侵入性的方法,它可以识别出存在症状性乳糖吸收不良的系统性硬化症患者,这些患者可能受益于减少乳糖摄入。